In contrast to moderate activation, excess levels of p53 could lead to undesired cellular fates, including hepatocyte injury followed by cell death, which in NAFLD are strongly linked to disease progression. This evidence concerns the gene TP53 and metabolic dysfunction-associated steatotic liver disease.